Your browser doesn't support javascript.
loading
Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates.
Lee, Shwu-Maan; Wu, Chia-Kuei; Plieskatt, Jordan; McAdams, David H; Miura, Kazutoyo; Ockenhouse, Chris; King, C Richter.
Afiliação
  • Lee SM; PATH Malaria Vaccine Initiative (MVI), 455 Massachusetts Avenue NW, Suite 1000, Washington, DC, 20001-2621, USA. smlee@path.org.
  • Wu CK; PATH Malaria Vaccine Initiative (MVI), 455 Massachusetts Avenue NW, Suite 1000, Washington, DC, 20001-2621, USA.
  • Plieskatt J; PATH Malaria Vaccine Initiative (MVI), 455 Massachusetts Avenue NW, Suite 1000, Washington, DC, 20001-2621, USA.
  • McAdams DH; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA, 98121, USA.
  • Miura K; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, 20852, USA.
  • Ockenhouse C; PATH Malaria Vaccine Initiative (MVI), 455 Massachusetts Avenue NW, Suite 1000, Washington, DC, 20001-2621, USA.
  • King CR; PATH Malaria Vaccine Initiative (MVI), 455 Massachusetts Avenue NW, Suite 1000, Washington, DC, 20001-2621, USA.
Malar J ; 15(1): 405, 2016 08 11.
Article em En | MEDLINE | ID: mdl-27515826

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Proteínas de Protozoários / Vacinas Antimaláricas / Transmissão de Doença Infecciosa / Malária Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Proteínas de Protozoários / Vacinas Antimaláricas / Transmissão de Doença Infecciosa / Malária Idioma: En Ano de publicação: 2016 Tipo de documento: Article